NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Endava plc (NYSE:DAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/endava-lawsuit-submission-form?prid=103924&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) […]

Operational efficiencies and margin improvements drive profitability turnaround Higher-margin DTC sales increased to 36% of gross revenue in FY24 Strengthened balance sheet with 45% reduction in revolver debt and added new $120M credit facility PLANTATION, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a global distributor and wholesaler specializing in

Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat presentation at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference on Thursday, Sept. 26, 2024 at 9:20 a.m. EDT (2:20 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for

QuarterlyPSN Top Guns List published by Zephyr identifies best-in-class separate accounts, managed accounts, and managed ETF strategies. Financial Trust Asset Managementannounced today it has been named to the celebrated PSN Top Guns List of best performing separate accounts, managed accounts, and managed ETF strategies for Q2 2024. The highly anticipated list, published by Zephyr, remains

Attorney Advertising –Bronstein,Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ: ALLR) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws

Attorney Advertising — Bronstein,Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Coinbase Global, Inc. (“Coinbase” or “the Company”) (NASDAQ: COIN) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities

Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofMineralys Therapeutics, Inc. (“Mineralys” or “the Company”) (NASDAQ: MLYS). Investors who purchased Mineralys securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MLYS. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Investigation Details On August 13, 2024, Mineralys released

Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed againstAgenus Inc. (“Agenus” or “the Company”) (NASDAQ: AGEN) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws

Attorney Advertising –Bronstein,Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Napco Security Technologies, Inc. (“Napco” or “the Company”) (NASDAQ: NSSC). Investors who purchased Napco securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NSSC. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Investigation Details On September 5, 2024, Fuzzy Panda

Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions on September 27, 2024 and